Intratumoral immune triads are required for effective immunotherapy

NCI Division of Cancer Biology shared on X:

“Using preclinical models in an NCI-funded study, Gabriel Espinosa Carrasco, The SchietiLab, et al. found that intratumoral immune triads (with a dendritic cell, CD4 T cell, and CD8 T cell) are required for effective immunotherapy.”

Intratumoral immune triads are required for immunotherapy-mediated elimination of solid tumors

Authors: Gabriel Espinosa-Carrasco, Edison Chiu, Aurora Scrivo, Paul Zumbo, Asim Dave, Doron Betel, Sung Wook Kang, Hee-Jin Jang, Matthew D. Hellmann, Bryan M. Burt, Hyun-Sung Lee, Andrea Schietinger 

Source: NCI Division of Cancer Biology/X